대웅제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 국민연금공단, was filed 07 Jul 2026.
대웅제약: what insiders have been doing
대웅제약, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Between 2 November 2025 and 2 November 2026, 4 insiders published 7 filings.
The record shows 3 purchases on the open market, made by 1 insider, against 2 sales by 2 insiders. The totals do not cover 5 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The most recent open-market purchase was published on 7 July 2026, 126 days ago.
With 7 filings in twelve months, the company is in line with the median of 7 filings across the 2,655 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 18 purchases and 4 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 1,170,516 sharesShareKRXDART:20260707000328Canonical exit: 5 Oct 2026 (T+90)
- 5,000 sharesKRXDART:20260326001509
- 2,472 shares@ ₩174,894.44550.79% mcap100.0% of flowShareKRXDART:20260325000954
- ●Executives0DART
- 1,159,614 sharesShareKRXDART:20260213002246Canonical exit: 14 May 2026 (T+90)
- 39,366 sharesShareKRXDART:20260126000284
- 20,231 sharesShareKRXDART:20260105000289Canonical exit: 5 Apr 2026 (T+90)
- 120,788 sharesKRXDART:20251001000504
- 194,963 sharesShareKRXDART:20251001000403
- 92,957 sharesShareKRXDART:20250703000356Canonical exit: 1 Oct 2025 (T+90)
- 74,004 sharesShareKRXDART:20250107000336Canonical exit: 7 Apr 2025 (T+90)
- 118,959 sharesKRXDART:20250106000220Canonical exit: 21 Jan 2025 (T+90)
- ShareKRXDART:20241008000555Canonical exit: 20 Nov 2024 (T+90)
- 236,961 sharesKRXDART:20241007000316Canonical exit: 10 Oct 2024 (T+90)
- ShareKRXDART:20240827000015Canonical exit: 19 Nov 2024 (T+90)
- ShareKRXDART:20231019000273
- ShareKRXDART:20231006000564
- 236,961 sharesKRXDART:20231005000260Canonical exit: 18 Oct 2023 (T+90)
- ShareKRXDART:20230922000437
- ShareKRXDART:20230914000336
- ShareKRXDART:20230906000395
- ShareKRXDART:20230829000662
- ShareKRXDART:20230821000497
25 of 49 declarations
About 대웅제약
Daewoong Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the Korea Exchange, XKRX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
